Stockscreener 앱 받기
17.53
6.53%
-1.225
시간 외 거래:
17.51
-0.02
-0.11%
전일 마감가:
$18.75
열려 있는:
$18.1
하루 거래량:
629.17K
Relative Volume:
0.50
시가총액:
$153.67M
수익:
-
순이익/손실:
$-121.02M
주가수익비율:
-1.5568
EPS:
-11.26
순현금흐름:
$-114.09M
1주 성능:
-10.06%
1개월 성능:
-26.96%
6개월 성능:
-12.35%
1년 성능:
+23.62%
1일 변동 폭
$17.50
$18.84
1주일 범위
$17.50
$19.33
52주 변동 폭
$7.31
$130.00
토닉스 파마슈티컬스 홀딩 Stock (TNXP) Company Profile
명칭
Tonix Pharmaceuticals Holding Corp
전화
212-980-9155
주소
26 MAIN STREET, SUITE 101, CHATHAM, NY
TNXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
17.53 | 215.22M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
토닉스 파마슈티컬스 홀딩 Stock (TNXP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-04-18 | 개시 | Noble Capital Markets | Outperform |
| 2019-04-18 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2017-08-18 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2016-09-07 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2016-02-17 | 재확인 | Oppenheimer | Outperform |
| 2015-11-04 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-12 | 개시 | Oppenheimer | Outperform |
| 2015-02-17 | 재확인 | ROTH Capital | Buy |
| 2014-09-29 | 재확인 | ROTH Capital | Buy |
모두보기
토닉스 파마슈티컬스 홀딩 주식(TNXP)의 최신 뉴스
Tonix Pharmaceuticals (TNXP) Partners for Kidney Transplant Tria - GuruFocus
Tonix, Mass General partner on Phase 2 trial of TNX-1500 to prevent kidney transplant organ rejection - MarketScreener
Tonix to evaluate TNX-1500 in kidney transplant recipients with MGH - Investing.com
Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection - Stock Titan
Risk vs reward if holding onto Tonix Pharmaceuticals Holding Corp.CPI Data & Fast Moving Trade Plans - newser.com
Will Tonix Pharmaceuticals Holding Corp. stock deliver shareholder valueEarnings Overview Report & Advanced Swing Trade Entry Plans - newser.com
How Tonix Pharmaceuticals Holding Corp. stock responds to policy changes2025 Technical Patterns & Weekly Momentum Picks - newser.com
Will Tonix Pharmaceuticals Holding Corp. stock deliver strong dividend growthWeekly Trading Summary & Community Verified Trade Signals - newser.com
Volatility clustering patterns for Tonix Pharmaceuticals Holding Corp.Weekly Trade Report & Low Risk Entry Point Guides - newser.com
Can Tonix Pharmaceuticals Holding Corp. stock deliver strong Q4 earningsJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Is Tonix Pharmaceuticals Holding Corp. stock trading at a premium valuationEarnings Overview Report & Weekly High Potential Stock Alerts - newser.com
How to build a dashboard for Tonix Pharmaceuticals Holding Corp. stockJuly 2025 Big Picture & Trade Opportunity Analysis - newser.com
Is Tonix Pharmaceuticals Holding Corp. stock a safe haven assetQuarterly Profit Report & Community Verified Watchlist Alerts - newser.com
Sentiment analysis tools applied to Tonix Pharmaceuticals Holding Corp.Analyst Downgrade & Safe Capital Preservation Plans - newser.com
Tonix Pharmaceuticals Holding Corp. stock trend forecastQuarterly Market Summary & Daily Price Action Insights - newser.com
Real time alert setup for Tonix Pharmaceuticals Holding Corp. performanceJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - newser.com
What drives Tonix Pharmaceuticals Holding Corp stock priceMarket Sentiment Report & Exceptional Return Stocks - earlytimes.in
Tonix Pharmaceuticals Holding Corp. (TNXP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Tonix Pharmaceuticals Holding Corp. (TNXP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Tonix Pharma. Holding Corp. R (TPM0.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
How to recover losses in Tonix Pharmaceuticals Holding Corp. stockJuly 2025 Levels & Risk Controlled Daily Plans - newser.com
Tonix Pharma. Holding Corp. R (TPM0.F) stock price, news, quote and history - Yahoo! Finance UK
Tonix Pharmaceuticals Holding Corp (TNXP) Showcases Promising TNX-801 Vaccine Data - Insider Monkey
토닉스 파마슈티컬스 홀딩 (TNXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):